| Alternate day fasting improves physiological and molecular markers of aging in healthy, non-obese humans S Stekovic, SJ Hofer, N Tripolt, MA Aon, P Royer, L Pein, JT Stadler, ... Cell metabolism 30 (3), 462-476. e6, 2019 | 346 | 2019 |
| Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes RR Holman, H Sourij, RM Califf The Lancet 383 (9933), 2008-2017, 2014 | 286 | 2014 |
| Diabetic cardiomyopathy: current and future therapies. Beyond glycemic control G Borghetti, D Von Lewinski, DM Eaton, H Sourij, SR Houser, M Wallner Frontiers in physiology 9, 1514, 2018 | 223 | 2018 |
| Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European … O Moser, MC Riddell, ML Eckstein, P Adolfsson, R Rabasa-Lhoret, ... Diabetologia 63 (12), 2501-2520, 2020 | 222 | 2020 |
| Short-term effects of high-dose oral vitamin D3 in critically ill vitamin D deficient patients: a randomized, double-blind, placebo-controlled pilot study K Amrein, H Sourij, G Wagner, A Holl, TR Pieber, KH Smolle, T Stojakovic, ... Critical care 15, 1-7, 2011 | 207 | 2011 |
| Empagliflozin in acute myocardial infarction: the EMMY trial D von Lewinski, E Kolesnik, NJ Tripolt, PN Pferschy, M Benedikt, ... European heart journal 43 (41), 4421-4432, 2022 | 152 | 2022 |
| Evaluation of subcutaneous glucose monitoring systems under routine environmental conditions in patients with type 1 diabetes F Aberer, M Hajnsek, M Rumpler, S Zenz, PM Baumann, H Elsayed, ... Diabetes, Obesity and Metabolism 19 (7), 1051-1055, 2017 | 147 | 2017 |
| Multicentric validation of proteomic biomarkers in urine specific for diabetic nephropathy A Alkhalaf, P Zürbig, SJL Bakker, HJG Bilo, M Cerna, C Fischer, S Fuchs, ... PloS one 5 (10), e13421, 2010 | 147 | 2010 |
| Empagliflozin protects heart from inflammation and energy depletion via AMPK activation CN Koyani, I Plastira, H Sourij, S Hallström, A Schmidt, PP Rainer, ... Pharmacological research 158, 104870, 2020 | 143 | 2020 |
| The influence of probiotic supplementation on gut permeability in patients with metabolic syndrome: an open label, randomized pilot study B Leber, NJ Tripolt, D Blattl, M Eder, TC Wascher, TR Pieber, R Stauber, ... European journal of clinical nutrition 66 (10), 1110-1115, 2012 | 138 | 2012 |
| Chronic TNF-α neutralization does not improve insulin resistance or endothelial function in “healthy” men with metabolic syndrome TC Wascher, JHN Lindeman, H Sourij, T Kooistra, G Pacini, M Roden Molecular medicine 17, 189-193, 2011 | 122 | 2011 |
| Effects of pioglitazone on endothelial function, insulin sensitivity, and glucose control in subjects with coronary artery disease and new-onset type 2 diabetes H Sourij, R Zweiker, TC Wascher Diabetes care 29 (5), 1039-1045, 2006 | 106 | 2006 |
| Therapeutic options to reduce advanced glycation end products in patients with diabetes mellitus: A review P Jud, H Sourij Diabetes research and clinical practice 148, 54-63, 2019 | 104 | 2019 |
| Rationale and design of the EXenatide Study of Cardiovascular Event Lowering (EXSCEL) trial RR Holman, MA Bethel, J George, H Sourij, Z Doran, J Keenan, ... American heart journal 174, 103-110, 2016 | 102 | 2016 |
| Effect of supplementation with Lactobacillus casei Shirota on insulin sensitivity, β-cell function, and markers of endothelial function and inflammation in subjects with … NJ Tripolt, B Leber, D Blattl, M Eder, W Wonisch, H Scharnagl, ... Journal of dairy science 96 (1), 89-95, 2013 | 94 | 2013 |
| Effect of Lactobacillus casei Shirota supplementation on trimethylamine-N-oxide levels in patients with metabolic syndrome: An open-label, randomized study NJ Tripolt, B Leber, A Triebl, H Köfeler, V Stadlbauer, H Sourij Atherosclerosis 242 (1), 141-144, 2015 | 89 | 2015 |
| Key role of postchallenge hyperglycemia for the presence and extent of coronary atherosclerosis: an angiographic study CH Saely, H Drexel, H Sourij, S Aczel, H Jahnel, R Zweiker, P Langer, ... Atherosclerosis 199 (2), 317-322, 2008 | 86 | 2008 |
| Glycaemic control in acute coronary syndromes: prognostic value and therapeutic options R De Caterina, R Madonna, H Sourij, T Wascher European heart journal 31 (13), 1557-1564, 2010 | 83 | 2010 |
| Low-dose atorvastatin improves dyslipidemia and vascular function in patients with primary biliary cirrhosis after one year of treatment T Stojakovic, T Claudel, C Putz-Bankuti, G Fauler, H Scharnagl, ... Atherosclerosis 209 (1), 178-183, 2010 | 79 | 2010 |
| Performance of the Freestyle Libre flash glucose monitoring (flash GM) system in individuals with type 1 diabetes: A secondary outcome analysis of a randomized crossover trial O Moser, ML Eckstein, O McCarthy, R Deere, J Pitt, DM Williams, J Hayes, ... Diabetes, Obesity and Metabolism 21 (11), 2505-2512, 2019 | 78 | 2019 |
